Literature DB >> 26586818

Functional Deficiencies in Fragile X Neurons Derived from Human Embryonic Stem Cells.

Michael Telias1, Liron Kuznitsov-Yanovsky1, Menahem Segal2, Dalit Ben-Yosef3.   

Abstract

Fragile X syndrome (FXS), the most common form of inherited mental retardation, is a neurodevelopmental disorder caused by silencing of the FMR1 gene, which in FXS becomes inactivated during human embryonic development. We have shown recently that this process is recapitulated by in vitro neural differentiation of FX human embryonic stem cells (FX-hESCs), derived from FXS blastocysts. In the present study, we analyzed morphological and functional properties of neurons generated from FX-hESCs. Human FX neurons can fire single action potentials (APs) to depolarizing current commands, but are unable to discharge trains of APs. Their APs are of a reduced amplitudes and longer durations than controls. These are reflected in reduced inward Na(+) and outward K(+) currents. In addition, human FX neurons contain fewer synaptic vesicles and lack spontaneous synaptic activity. Notably, synaptic activity in these neurons can be restored by coculturing them with normal rat hippocampal neurons, demonstrating a critical role for synaptic mechanisms in FXS pathology. This is the first extensive functional analysis of human FX neurons derived in vitro from hESCs that provides a convenient tool for studying molecular mechanisms underlying the impaired neuronal functions in FXS. SIGNIFICANCE STATEMENT: Fragile X syndrome (FXS), the most common form of inherited mental retardation, is caused by silencing of the FMR1 gene. In this study, we describe for the first time the properties of neurons developed from human embryonic stem cells (hESCs) that carry the FMR1 mutation and are grown in culture for extended periods. These neurons are retarded compared with controls in several morphological and functional properties. In vitro neural differentiation of FX hESCs can thus serve as a most relevant system for the analysis of molecular mechanisms underlying the impaired neuronal functions in FXS.
Copyright © 2015 the authors 0270-6474/15/3515295-12$15.00/0.

Entities:  

Keywords:  action potential; disease modeling; fragile X syndrome; human embryonic stem cells; in vitro neural differentiation; synaptic deficiencies

Mesh:

Substances:

Year:  2015        PMID: 26586818      PMCID: PMC6605488          DOI: 10.1523/JNEUROSCI.0317-15.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  47 in total

1.  Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination.

Authors:  S A Irwin; B Patel; M Idupulapati; J B Harris; R A Crisostomo; B P Larsen; F Kooy; P J Willems; P Cras; P B Kozlowski; R A Swain; I J Weiler; W T Greenough
Journal:  Am J Med Genet       Date:  2001-01-15

2.  Abnormal presynaptic short-term plasticity and information processing in a mouse model of fragile X syndrome.

Authors:  Pan-Yue Deng; David Sojka; Vitaly A Klyachko
Journal:  J Neurosci       Date:  2011-07-27       Impact factor: 6.167

Review 3.  Modeling neurodevelopmental disorders using human neurons.

Authors:  Thanathom Chailangkarn; Allan Acab; Alysson Renato Muotri
Journal:  Curr Opin Neurobiol       Date:  2012-06-19       Impact factor: 6.627

4.  Bidirectional regulation of dendritic voltage-gated potassium channels by the fragile X mental retardation protein.

Authors:  Hye Young Lee; Woo-Ping Ge; Wendy Huang; Ye He; Gordon X Wang; Ashley Rowson-Baldwin; Stephen J Smith; Yuh Nung Jan; Lily Yeh Jan
Journal:  Neuron       Date:  2011-11-17       Impact factor: 17.173

Review 5.  The pathophysiology of fragile x syndrome.

Authors:  Olga Penagarikano; Jennifer G Mulle; Stephen T Warren
Journal:  Annu Rev Genomics Hum Genet       Date:  2007       Impact factor: 8.929

6.  Timing of the absence of FMR1 expression in full mutation chorionic villi.

Authors:  Rob Willemsen; Carola J M Bontekoe; Lies-Anne Severijnen; Ben A Oostra
Journal:  Hum Genet       Date:  2002-04-16       Impact factor: 4.132

7.  Neural differentiation of Fragile X human Embryonic Stem Cells reveals abnormal patterns of development despite successful neurogenesis.

Authors:  Michael Telias; Menahem Segal; Dalit Ben-Yosef
Journal:  Dev Biol       Date:  2012-12-05       Impact factor: 3.582

Review 8.  Insights into GABAAergic system deficits in fragile X syndrome lead to clinical trials.

Authors:  Sien Braat; R Frank Kooy
Journal:  Neuropharmacology       Date:  2014-07-10       Impact factor: 5.250

9.  Modest alterations in patterns of motor neuron dendrite morphology in the Fmr1 knockout mouse model for fragile X.

Authors:  Christina C Thomas; Crescent L Combe; Kenneth A Dyar; Fiona M Inglis
Journal:  Int J Dev Neurosci       Date:  2008-06-21       Impact factor: 2.457

10.  Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling.

Authors:  Stuart M Chambers; Christopher A Fasano; Eirini P Papapetrou; Mark Tomishima; Michel Sadelain; Lorenz Studer
Journal:  Nat Biotechnol       Date:  2009-03-01       Impact factor: 54.908

View more
  26 in total

1.  The fragile X mutation impairs homeostatic plasticity in human neurons by blocking synaptic retinoic acid signaling.

Authors:  Zhenjie Zhang; Samuele G Marro; Yingsha Zhang; Kristin L Arendt; Christopher Patzke; Bo Zhou; Tyler Fair; Nan Yang; Thomas C Südhof; Marius Wernig; Lu Chen
Journal:  Sci Transl Med       Date:  2018-08-01       Impact factor: 17.956

2.  Molecular analyses of neurogenic defects in a human pluripotent stem cell model of fragile X syndrome.

Authors:  Michael J Boland; Kristopher L Nazor; Ha T Tran; Attila Szücs; Candace L Lynch; Ryder Paredes; Flora Tassone; Pietro Paolo Sanna; Randi J Hagerman; Jeanne F Loring
Journal:  Brain       Date:  2017-03-01       Impact factor: 13.501

Review 3.  Human Models Are Needed for Studying Human Neurodevelopmental Disorders.

Authors:  Xinyu Zhao; Anita Bhattacharyya
Journal:  Am J Hum Genet       Date:  2018-12-06       Impact factor: 11.025

Review 4.  Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.

Authors:  Stephen J Haggarty; M Catarina Silva; Alan Cross; Nicholas J Brandon; Roy H Perlis
Journal:  Mol Cell Neurosci       Date:  2016-01-28       Impact factor: 4.314

Review 5.  Channelopathies in fragile X syndrome.

Authors:  Pan-Yue Deng; Vitaly A Klyachko
Journal:  Nat Rev Neurosci       Date:  2021-04-07       Impact factor: 34.870

6.  Immature Responses to GABA in Fragile X Neurons Derived from Human Embryonic Stem Cells.

Authors:  Michael Telias; Menahem Segal; Dalit Ben-Yosef
Journal:  Front Cell Neurosci       Date:  2016-05-12       Impact factor: 5.505

Review 7.  Dysfunctional mTORC1 Signaling: A Convergent Mechanism between Syndromic and Nonsyndromic Forms of Autism Spectrum Disorder?

Authors:  Juliana Magdalon; Sandra M Sánchez-Sánchez; Karina Griesi-Oliveira; Andréa L Sertié
Journal:  Int J Mol Sci       Date:  2017-03-18       Impact factor: 5.923

8.  Synaptic vesicle dynamic changes in a model of fragile X.

Authors:  Zhanmin Lin; H Martijn de Gruiter; Jantine A C Broek; Heleen van 't Spijker; Elize D Haasdijk; David Cox; Sureyya Ozcan; Gert W A van Cappellen; Adriaan B Houtsmuller; Rob Willemsen; Chris I de Zeeuw; Sabine Bahn
Journal:  Mol Autism       Date:  2016-03-01       Impact factor: 7.509

Review 9.  Modeling Fragile X Syndrome Using Human Pluripotent Stem Cells.

Authors:  Hagar Mor-Shaked; Rachel Eiges
Journal:  Genes (Basel)       Date:  2016-09-28       Impact factor: 4.096

10.  Loss of the fragile X mental retardation protein causes aberrant differentiation in human neural progenitor cells.

Authors:  Naohiro Sunamura; Shinzo Iwashita; Kei Enomoto; Taisuke Kadoshima; Fujio Isono
Journal:  Sci Rep       Date:  2018-08-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.